1. Home page
  2. Search

The role of oncogene HER2 in current management of gastric cancer

This item is provided by the institution :
National Documentation Centre (EKT)   

Repository :
National Archive of PhD Theses  | ΕΚΤ NA.Ph.D.   

see the original item page
in the repository's web site and access all digital files if the item*



Ο ρόλος του ογκογονιδίου HER2 σύγχρονη αντιμετώπιση του καρκίνου του στομάχου
The role of oncogene HER2 in current management of gastric cancer
Tsapralis, Dimitrios
Τσαπραλής, Δημήτριος
PhD Thesis
2013
Aim: Anti-HER2 therapy was recently applied to advanced gastric cancer with HER2 overexpression and/or amplification tested by immunohistochemistry (ICH) and fluorescent in situ hybridization (FISH). However, FISH is technically demanding and expensive. Chromogenic in situ hybridization (CISH) uses a chromogenic substrate similar to IHC. The slides are visible under light microscopy and show correlation with morphology. Our aim was to assess HER2 status by IHC and CISH in gastric cancer.Methods: 120 gastric carcinomas combined on a multiple-punch tissue microarray, including lymph node metastases in 45 patients, were examined for HER2 overexpression and gene amplification by IHC and CISH.Results: Twenty-four (20%) of 120 tumours expressed HER2 by IHC. An IHC score of ≥2+ was observed in 20 tumours (16.6%). HER2 amplification was detected by CISH in 19 tumours (15.8%) and their matched lymph node metastases . Amplification was associated with intestinal phenotype (p<0.05), but did not show association with grading, staging or survival.Conclusion: In gastric cancer HER2 amplification is the only mechanism for HER2 protein overexpression and is preserved in lymph node metastases. The evaluation of the expression of HER2 protein in patients with gastric adenocarcinoma should be done by immunohistochemistry (ICH) and be verified by in situ hybridization. Chromogenic in situ hybridization (CISH) can be used as an alternative for FISH in HER2 testing. Our data do not support the prognostic role of HER2 status in gastric cancer and, as a result, do not advocate the addition of molecular treatment in the form of trastuzumab in gastric cancer patients.
Ιατρική και Επιστήμες Υγείας ➨ Βασική Ιατρική
Immunohistochemistry
Προγνωστικός ρόλος
Basic Medicine
Χρωμογενής in situ υβριδισμός
Medical and Health Sciences
Oncogene HER2
Ογκογονίδιο HER2
Chromogenic in situ hybridization
Γαστρικός καρκίνος
Ανοσοϊστοχημεία
Survival
Επιβίωση
Tissue microarrays
Prognostic role
Βασική Ιατρική
Ιστικές μικροσυστοιχίες
Gastric cancer
Ιατρική και Επιστήμες Υγείας
Greek
National and Kapodistrian University of Athens
Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)
Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής. Τομέας Χειρουργικής. Κλινική Γ' Χειρουργική Πανεπιστημιακού Γενικού Νοσοκομείου ΑΤΤΙΚΟΝ
National Documentation Centre (EKT)
National Archive of PhD Theses
Συλλογή ΕΑΔΔ



*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)